Compare Honda Motor Company Ltd. Common Stock (HMC) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honda Motor Company Ltd. Common Stock vs Repligen Corporation Common Stock — how do they compare? Honda Motor Company Ltd. Common Stock trades at $33.74 (market cap $43.08B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Honda Motor Company Ltd. Common Stock is far larger — about 3.9× Repligen Corporation Common Stock's market cap, and Honda Motor Company Ltd. Common Stock pays a 4% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honda Motor Company Ltd. Common Stock for 6 Days and Repligen Corporation Common Stock for 0 Days on average.
| HMC | RGEN | |
|---|---|---|
Market Cap | $43.08B | $11.14B |
Volume | 823,318 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $33.45 | $194.57 |
52-Week Low | $23.49 | $102.87 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $40.26B | $11.02B |
Dividend Yield | 4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honda Motor Co. (HMC) trades at $33.33, up 2.05% with strong technical momentum and bullish moving average signals. The company shows mixed fundamentals with revenue growth to $22.5T in 2026 but negative net income margins, while valuation metrics appear attractive with P/S of 0.32 and EV/EBITDA of 4.92. Recent news highlights strategic investments in hybrid technology and cost-cutting initiatives.
HMC presents a value opportunity with reasonable valuations and positive earnings surprises, though profitability challenges and competitive pressures create headwinds. Analyst consensus leans moderate buy with institutional interest, but investors should weigh cost reduction progress against margin pressures in the evolving auto industry.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honda Motor Company Ltd. Common Stock
Honda Motor manufactures automobiles, motorcycles, power products, and related financial services. Its brands serve consumer and commercial transportation markets globally.
Read more on HMC →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
